EW Stock
Edwards Lifesciences Corp
$101.88
+0.00% today
YTD +19.5%
Price
Daily closes via Alpaca (IEX); today's point is the latest trade.
Key stats
52-week range
$75.84
$107.94
Valuation
P/E (trailing)58.1
Forward P/E33.8
Price / sales8.9
Price / book4.6
EPS (12 mo)$1.76
Beta0.68
Financial health last 12 months
Revenue growth+13.4%
Earnings growth-24.2%
Gross margin78.0%
Net margin+15.3%
Return on equity9.7%
Debt / equity0.06
Hover a figure for what it means.
Analyst ratings Nov 2026 · 39 analysts
Consensus: Buy
Strong buy 13Buy 19
Hold 7Sell 0
Strong sell 0
| Month | Buy | Hold | Sell | Consensus |
|---|---|---|---|---|
| Nov 2026 | 32 | 7 | 0 | Buy |
| Oct 2026 | 31 | 7 | 0 | Buy |
| Sep 2026 | 31 | 9 | 0 | Buy |
| Aug 2026 | 30 | 10 | 0 | Buy |
Latest news
Is Buying Edwards Stock At Its High A Bad Idea?
Yahoo · 1d ago
Edwards Lifesciences Corporation Enters into $750 million Amended and Restated Credit Agreement
Fintel · 2d ago
BSX's Weak Solvency and Cash Conversion Raise Financing Risk
Yahoo · 2d ago
Anaconda Biomed Names Omar Azanki Chief Technology Officer
Yahoo · 2d ago
Should You Buy GE HealthCare Stock For Its Cash?
Yahoo · 3d ago
Edwards Lifesciences: Momentum Returns, But Valuation Warrants Caution
SeekingAlpha · 3d ago
How Long Can HeartFlow Keep Burning Cash?
Yahoo · 4d ago
Boston Scientific: A Longer Road To Recovery (Rating Downgrade)
SeekingAlpha · 5d ago
Headlines from the last 10 days via Finnhub; links open the publisher's article.
Next earnings
No report scheduled in the next 4 months.
Past earnings moves
No tracked reports yet. TradeSphere saves the expected and actual move for every report from Nov 3, 2026 on, for stocks on the Earnings page.